You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-XIAP antibody [2F1] (ab28151)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-XIAP antibody [2F1]
See all XIAP products (9) ...

Description

Mouse monoclonal [2F1] to XIAP

Tested applications

Flow Cyt, WB, IPmore details

Cross reactivity

Reacts with

Mouse, Human

Immunogen

Fusion protein with Human XIAP.

Epitope

ab28151 reacts with an epitope located in the C terminal region encoded by aa 352/449 of XIAP.

Positive control

HeLa Cell Lysate

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: 50% Glycerol, PBS, pH 7.2

Concentration

Concentration information loading...

Purity

Protein A purified

Clonality

Monoclonal

Clone number

2F1

Isotype

IgG1

  • Flow Cytometry-XIAP antibody [2F1](ab28151)Flow Cytometry-XIAP antibody [2F1](ab28151) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab28151 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Apoptotic suppressor. Has E3 ubiquitin-protein ligase activity. Mediates the proteasomal degradation of target proteins, such as caspase-3, SMAC or AIFM1. Inhibitor of caspase-3, -7 and -9. Mediates activation of MAP3K7/TAK1, leading to the activation of NF-kappa-B.

Tissue specificity

Ubiquitous, except peripheral blood leukocytes.

Involvement in disease

Defects in XIAP are the cause of lymphoproliferative syndrome X-linked type 2 (XLP2) [MIM:300635]. XLP is a rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus (EBV). Symptoms include severe or fatal mononucleosis, acquired hypogammaglobulinemia, pancytopenia and malignant lymphoma.

Sequence similarities

Belongs to the IAP family.
Contains 3 BIR repeats.
Contains 1 RING-type zinc finger.

Domain

The first BIR domain is involved in interaction with TAB1/MAP3K7IP1 and is important for dimerization. The second BIR domain is sufficient to inhibit caspase-3 and caspase-7, while the third BIR is involved in caspase-9 inhibition. The interactions with SMAC and PRSS25 are mediated by the second and third BIR domains.

Post-translational
modifications

Ubiquitinated and degraded by the proteasome in apoptotic cells.
Phosphorylation by PKB/AKT protects XIAP against ubiquitination and protects the protein against proteasomal degradation.

Cellular localization

Cytoplasm.

Target information above from: UniProt accessionP98170 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • AP 13 antibody
  • API3 antibody
  • API3 antibody
  • Apoptosis Inhibitor 3 antibody
  • Apoptosis Inhibitor 3 antibody
  • Baculoviral IAP repeat containing 4 antibody
  • Baculoviral IAP Repeat Containing Protein 4 antibody
  • Baculoviral IAP Repeat Containing Protein 4 antibody
  • Baculoviral IAP repeat-containing protein 4 antibody
  • BIRC 4 antibody
  • BIRC4 antibody
  • BIRC4 antibody
  • E3 ubiquitin-protein ligase XIAP antibody
  • hIAP-3 antibody
  • hIAP3 antibody
  • HILP antibody
  • IAP 3 antibody
  • IAP like protein antibody
  • IAP-3 antibody
  • IAP-like protein antibody
  • IAP3 antibody
  • ILP 1 antibody
  • ILP antibody
  • ILP1 antibody
  • ILP1 antibody
  • Inhibitor of apoptosis protein 3 antibody
  • Inhibitor of Apoptosis X Linked antibody
  • Inhibitor of Apoptosis X Linked antibody
  • Mammalian IAP Homologue A antibody
  • Mammalian IAP Homologue A antibody
  • MIHA antibody
  • MIHA antibody
  • X linked IAP antibody
  • X linked inhibitor of apoptosis antibody
  • X linked inhibitor of apoptosis protein antibody
  • X-linked IAP antibody
  • X-linked inhibitor of apoptosis protein antibody
  • Xiap antibody
  • XIAP_HUMAN antibody
  • XLP2 antibody
see all

Anti-XIAP antibody [2F1] images:

  Flow Cytometry-XIAP antibody [2F1](ab28151)

Flow Cytometry-XIAP antibody [2F1](ab28151)

Overlay histogram showing HeLA cells stained with ab28151 (red line). The cells were fixed with 100% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab28151, 2µg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was Mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

References for Anti-XIAP antibody [2F1] (ab28151)

This product has been referenced in:

  • Jost PJet al. XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 460:1035-9 (2009). WB, IP; Mouse.Read more (PubMed: 19626005) »
  • Ali Set al. The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity. Cancer Res 69:6208-15 (2009). WB; Human.Read more (PubMed: 19638587) »

See all 3 publications for this product

Publishing research using ab28151? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"